bibliographic entry 5726424 [be/5726424]
https://w3id.org/oc/corpus/be/5726424

is a

• bibliographic reference

content

• Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, et al Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Neurology. 2014; 13(6): 545–56. doi: 10.1016/S1474-4422(14)70049-3 PMID: 24685276

references

• https://w3id.org/oc/corpus/br/3277434